PrimeRFP SCOUT · Federal Contract Recompete Brief

75A50326F80004Amoxicillin trihydrate 500mg 60 CT and — Usantibiotics LLC

Usantibiotics LLC holds $30.0M across 2 federal awards, concentrated at Department of Health and Human Services (HHS). The prior award was single-bid — competitive dynamics may favor a challenge. Recompete timing centers on the May 28, 2027 PoP end — agencies typically plan 12–18 months ahead.

Aspr/Orm-Sns

Awarding office

Usantibiotics LLC

Recipient

May 28, 2027

PoP end

$30M

Obligated

325412

NAICS

6505

PSC

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Usantibiotics LLC — $90

Contract facts

Federal

Contract number75A50326F80004

Also listed as36F79723D0101-75A50326F80004

AgencyAspr/Orm-Sns

Awarding officeAspr/Orm-Sns

IncumbentUsantibiotics LLC

UEIEKDEDWH14QT3

NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505

Parent IDIQ / IDV36F79723D0101

Place of performanceBRISTOL, TN

PoP end (current)May 28, 2027

Obligated$30M

AMOXICILLIN TRIHYDRATE 500MG 60 CT AND 100 CT ORAL CAPSULES is a federal award for Aspr/Orm-Sns held by Usantibiotics LLC. Estimated value $30M ($30M obligated). Current period of performance ends May 28, 2027. Last award drew 1 bidder. Place of performance: BRISTOL, TN.

AMOXICILLIN TRIHYDRATE 500MG 60 CT AND 100 CT ORAL CAPSULES

Recompete timing

Public

● Expiring in 281 days

Current PoP ends May 28, 2027 (281 days remaining). Agencies typically plan 12–18 months ahead — at 9.2 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Usantibiotics LLC — $30.0M obligated across 2 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)

Department of Health and Human Services (HHS)$30.0M · 100% of firm total

Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 75A50326F80004?

75A50326F80004 (Amoxicillin trihydrate 500mg 60 CT and) is a Aspr/Orm-Sns award with an estimated value of $30M, currently held by Usantibiotics LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75A50326F80004?

Aspr/Orm-Sns awarded 75A50326F80004 to Usantibiotics LLC.

Who is the incumbent on 75A50326F80004?

Usantibiotics LLC is the incumbent with $30.0M across 2 related awards in SCOUT’s public footprint. The current period of performance ends May 28, 2027.

When does Usantibiotics LLC’s 75A50326F80004 come up for recompete?

SCOUT tracks a period-of-performance end of May 28, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 20, 2026 · refreshed monthlyLatest procurement action May 27, 2026